Platform

Taking drug discovery to a new dimension

At PharmEnable Therapeutics we harness the power of chemical novelty, diversity and 3-dimensionality to design innovative therapies for hard-to-drug conditions.

With our proprietary drug discovery platform we can unlock challenging biological targets and ultimately improve patients’ lives.

Novelty

EXPLORING NOVEL CHEMICAL SPACE

Unlocking astronomic possibilities of drug-like small molecules that are IP-free from the start.

PharmEnable Therapeutics - 3D molecules icon

3-DIMENSIONALITY AND COMPLEXITY

Replicating the specificity of biologics to tackle challenging targets and minimise unwanted side effects.

PharmEnable Therapeutics - Diversity Generating Methods Icon

POWERED BY CHEMICAL DIVERSITY

Enabling the rapid and efficient discovery of multiple chemical series from a small number of starting molecules.

Synthetic Accessibility

SYNTHETIC ACCESSIBILITY

Averaging 5 synthetic steps, with a >90% synthetic success rate across all molecules.

Unlocking chemical space to design innovative drugs

chemSAILOR

A hybrid human/AI-based intelligent cheminformatics system that identifies the most suitable regions of chemical space and proposes the best chemical synthetic options to deliver active molecules against a given biological target.

chemUNIVERSE

Our proprietary and unique accessible chemical space. It is composed of novel virtual compounds with a high degree of complexity and diversity to ensure an efficient coverage of chemical space.

chemSEEK

A multicomponent and modular system of state-of-the-art AI methods and gold standard computational tools for efficiently mining chemUNIVERSE for a given biological target.